# Precigen, Inc. (PGEN)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/PGEN/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2025 | $ 9.92M | $ -256.64M | $ -92.59M | N/A | $ 20.91M |
| 2024 | $ 4.13M | $ -132.68M | $ -80.68M | $ 5.50M | $ 38.51M |
| 2023 | $ 6.73M | $ -103.70M | $ -74.03M | $ 7.10M | $ 118.50M |
| 2022 | $ 30.06M | $ 31.63M | $ -78.16M | $ 51.42M | $ 126.26M |
| 2021 | $ 16.96M | $ -109.55M | $ -74.91M | $ 190.07M | $ 107.35M |
| 2020 | $ 131.44M | $ -218.09M | $ -107.71M | $ 182.28M | $ 67.17M |
| 2019 | $ 117.10M | $ -416.04M | $ -224.35M | $ 232.67M | $ 71.71M |
| 2018 | $ 217.58M | $ -667.16M | $ -219.01M | $ 212.26M | $ 362.86M |
| 2017 | $ 311.49M | $ -157.64M | $ -203.15M | $ 8.27M | $ 533.63M |
| 2016 | $ 262.68M | $ -256.75M | $ -120.53M | $ 8.77M | $ 560.24M |
| 2015 | $ 243.75M | $ -118.63M | $ 32.18M | $ 9.09M | $ 694.08M |
| 2014 | $ 101.64M | $ -115.62M | $ -37.06M | $ 12.64M | $ 384.76M |
| 2013 | $ 34.18M | $ -55.59M | $ -78.52M | $ 1.69M | $ 366.72M |
| 2012 | $ 20.10M | $ -118.21M | $ -99.65M | $ 91.0K | $ -321.55M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Liabilities / Eq | 6.49 |
| Current Ratio | 3.09 |

## Other views

- [Metrics](https://sponda.capital/en/PGEN.md)
- [Charts](https://sponda.capital/en/PGEN/charts.md)
- [Compare](https://sponda.capital/en/PGEN/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.